European venture capital firm Wellington Ventures' Wellington Partners Life Science Fund V raised €210 million at its final close.

The fund attracted international investment from new blue-chip investors including KfW Capital, Talanx and US-based UTIMCO, the University of Texas/Texas A&M Investment Co. Existing investors European Investment Fund and the European Investment Bank also participated in the fund.

The fund plans to build a portfolio of approximately 15 to 20 companies, ranging in focus from novel biotechnology platforms, new therapeutics and medical devices including selected investments in diagnostics and digital medicine.